logo
episode-header-image
Sep 2023
2h 16m

#270 ‒ Journal club with Andrew Huberman...

Peter Attia, MD
About this episode

View the Show Notes Page for This Episode

Become a Member to Receive Exclusive Content

Sign Up to Receive Peter’s Weekly Newsletter

Andrew Huberman, Professor of Neurobiology at Stanford University and host of the Huberman Lab podcast joins us in a special journal club episode. Peter and Andrew each present a recent paper that sparked their interests, delving into the findings, dissecting their significance, discussing potential confounders and limitations, and exploring remaining questions. Importantly, they share their methodologies for comprehending research studies, providing valuable insights for listeners to navigate this process independently. Peter presents an epidemiological study reevaluating a noteworthy metformin result that intrigued the anti-aging community, leading to discussions on metformin's geroprotective potential (or lack thereof) and the current lack of aging biomarkers. Andrew introduces a paper examining how our beliefs about the medications we take influence their biological effects, distinguishing the "belief effect" from a placebo effect and highlighting its exciting implications for the future.

We discuss:

  • The motivation behind this journal club conversation [2:45];
  • Why Peter chose a paper on metformin, how metformin works, and why it generated excitement as a longevity-enhancing agent [9:00];
  • Defining insulin resistance and its underlying causes [16:15];
  • Metformin as a first-line treatment for type 2 diabetes, and Peter’s evolving interest in metformin as a geroprotective drug [22:00];
  • Defining the term “geroprotection” [24:45];
  • The 2014 study that got the anti-aging community interested in metformin [26:00];
  • Peter presents the 2022 paper that repeats the analytical approach from the 2014 Bannister study [33:15];
  • Greater mortality in the metformin group: how results differed between the 2022 paper and the 2014 paper [40:00];
  • Understanding statistical significance, statistical power, sample size, and why epidemiology uses enormous cohorts [51:45];
  • Interpreting the hazard ratios from the 2022 metformin study, and the notable takeaways from the study [56:45];
  • Drugs that may extend lifespan, why Peter stopped taking metformin, and a discussion of caloric restriction [1:08:45];
  • Current thoughts on the use of metformin for longevity [1:21:00];
  • Could there be any longevity benefit to short periods of caloric restriction? [1:22:45];
  • Peter and Andrew’s process for reading scientific papers [1:26:45];
  • The biological effects of belief, and how “belief effects” differ from placebo effects [1:32:30];
  • The neurobiology of nicotine: a precursor conversation before delving into the paper Andrew chose [1:39:45];
  • Andrew presents a paper that demonstrates the impact of belief [1:45:30];
  • Analyzing the fascinating results of the Perl paper [1:54:30];
  • Exciting implications of the findings about “belief” reported by Perl and colleagues [2:03:15]; and
  • More.

Connect With Peter on TwitterInstagramFacebook and YouTube

Up next
Jul 7
Navigating bone health: early life influences and advanced strategies for improvement and injury prevention (#214 rebroadcast)
View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter’s Weekly Newsletter In this episode from July 2022, Peter dives deep into the topic of bone health and explains why this is an important topic for everyone, from childr ... Show More
1h 31m
Jun 30
#355 – Skincare strategies, the science of facial aging, and cosmetic-intervention guidance | Tanuj Nakra, M.D. & Suzan Obagi, M.D.
View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter’s Weekly Newsletter Tanuj Nakra and Suzan Obagi, two leading experts in aesthetic medicine, join Peter to explore the science of facial aging and skin health as well as ... Show More
2h 57m
Jun 23
#354 – What the dying can teach us about living well: lessons on life and reflections on mortality | BJ Miller, M.D. and Bridget Sumser, L.C.S.W.
View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter’s Weekly Newsletter BJ Miller, a hospice and palliative care physician, and Bridget Sumser, a licensed social worker specializing in serious illness and end-of-life car ... Show More
2h 16m
Recommended Episodes
Sep 2023
Journal Club With Dr. Peter Attia | Metformin for Longevity & the Power of Belief Effects
In this journal club episode, my guest is Stanford and Johns Hopkins-trained physician, Dr. Peter Attia, M.D., who is also the host of The Drive podcast and the author of the bestselling book "Outlive: The Science & Art of Longevity." We each present a scientific paper and discus ... Show More
2h 18m
Feb 2024
Dr. Nir Barzilai: Can This Drug Slow Aging? The Science Behind Metformin
View the Show Notes For This Episode Get Free Weekly Health Tips from Dr. Hyman Sign Up for Dr. Hyman’s Weekly Longevity Journal Get Ad-free Episodes & Dr. Hyman+ Audio Exclusives Dr. Nir Barzilai is a geroscientist, Chaired Professor of Medicine and Genetics, and the founder and ... Show More
1h 51m
Apr 2023
The Science of Longevity: Why Healthspan Matters More Than Lifespan with Dr Peter Attia #356
No one would argue that smoking is a killer. And no doctor would wait until a patient was showing early signs of cancer or heart disease before advising them to quit. Yet this is one of the few health scenarios where early prevention is given the evidence-based weight it deserves ... Show More
2h 27m
Nov 2023
The Truth About Sugar, Alcohol, Caffeine, Protein & Exercise with Neuroscientist Dr Tommy Wood #404
This extra special – and slightly different – episode of the podcast is for anyone who’s ever felt confused about best practice for good health. If you’ve wondered which diet is the best one for your health, or if you are confused about how much protein you should be consuming - ... Show More
2h 3m
Mar 2023
Dr. Peter Attia: Improve Vitality, Emotional & Physical Health & Lifespan
In this episode, my guest is Peter Attia, M.D. He completed his medical and advanced training at Stanford University School of Medicine, Johns Hopkins School of Medicine and the National Institutes of Health (NIH). Dr. Attia is host of the health and medicine podcast, The Drive, ... Show More
3h 25m
Sep 2019
How Diet Influences Everything From Gut Health to Decision Making
The health of our digestive system greatly impacts the health of our whole body. This is because our gut is designed to help us digest food, absorb nutrients, keep invaders out, and even produce helpful compounds like the neurotransmitter serotonin, among so many other powerful f ... Show More
10m 24s
Dec 2021
The Emerging Science Of Longevity with Peter Diamandis
This episode is brought to you by BiOptimizers, Athletic Greens, and Rupa Health. What if I told you we’ll reach a point in time where scientific breakthroughs will extend our lives by more than a year, for every year we are alive? This is called longevity escape velocity, and so ... Show More
1h 17m
Aug 2022
Peter Attia, MD On Becoming a Centenarian Decathlete, Metabolic Health & All Things Zone 2
Healthspan extension may pique your interest. But it’s the obsession of today’s guest, a physician and engineer focused on the applied science of longevity to reframe and improve how we live while challenging all we’ve been previously taught about the interaction of health, human ... Show More
2h 20m
Aug 2020
157: Nutrition Research: Epidemiology & NHANES – Yanni Papanikolaou
While RCT (Randomized Controlled Trail) studies are the gold standard, there’s no perfect research study or methodology - every approach will have it’s inherent advantages and disadvantages. Despite some criticism, NHANES (National Health and Nutrition Examination Survey) offers ... Show More
52m 2s
Dec 2017
#040 Dr. Eric Verdin on Ketogenic Diet Longevity, Beta-Hydroxybutyrate & HDAC Inhibitors
Eric M. Verdin Eric M. Verdin, M.D. is the fifth president and chief executive officer of the Buck Institute for Research on Aging and is a professor of Medicine at UCSF. Dr. Verdin's laboratory focuses on the role of epigenetic regulators in the aging process, the role of metabo ... Show More
1h 3m